1. DeToledo JC. Lidocaine and seizures. Ther Drug Monit 2000; 22(3): 320-2. doi: 10.1097/00007691-200006000- 00014.
2. Nickel JC, Jain P, Shore N, Anderson J, Giesing D, Lee H, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med 2012; 4(143): 143ra00. doi: 10.1126/scitranslmed.3003804.
3. Baselt RC. Disposition of Toxic Drugs & Chemicals in Man. Biomedical Publications; 2017.
4. Muroi Y, Chanda B. Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel. J Gen Physiol 2009; 133(1): 1-15. doi: 10.1085/ jgp.200810103.
5. Sekimoto K, Tobe M, Saito S. Local anesthetic toxicity: acute and chronic management. Acute Med Surg 2017; 4(2): 152-60. doi: 10.1002/ams2.265.
6. Gangadharan S, Nawathe P, Schleien CL. 40 - Cardiopulmonary resuscitation. In: Coté CJ, Lerman J, Anderson BJ, eds. A Practice of Anesthesia for Infants and Children. 6th ed. Philadelphia: Content Repository Only!; 2019. p. 908-20.e4. doi: 10.1016/b978-0-323-42974- 0.00040-9.
7. Dokken K, Fairley P. Sodium Channel Blocker Toxicity. Treasure Island, FL: StatPearls Publishing; 2020
8. Lee JT, Sanderson CR, Xuan W, Agar M. Lidocaine for cancer pain in adults: a systematic review and metaanalysis. J Palliat Med 2019; 22(3): 326-34. doi: 10.1089/ jpm.2018.0257.
9. Centini F, Fiore C, Riezzo I, Rossi G, Fineschi V. Suicide due to oral ingestion of lidocaine: a case report and review of the literature. Forensic Sci Int 2007; 171(1): 57-62. doi: 10.1016/j.forsciint.2006.05.003.